Suven Life Sciences Limited (BOM: 530239)
India
· Delayed Price · Currency is INR 119.80
-0.80 (-0.66%)
At close: Nov 14, 2024
Suven Life Sciences Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Net Income | -1,460 | -1,051 | -1,183 | -1,220 | -721.51 | -942.18 | Upgrade
|
| Depreciation & Amortization | 60.41 | 64.75 | 65.17 | 43.7 | 43.31 | 41.67 | Upgrade
|
| Other Amortization | 0.27 | 0.27 | 0.26 | 0.23 | 0.15 | 0.02 | Upgrade
|
| Loss (Gain) From Sale of Investments | -57.33 | -45.49 | -17.92 | -3.56 | -0.61 | 5.02 | Upgrade
|
| Other Operating Activities | -80.76 | -192.35 | -139.46 | -56.52 | -134.54 | -278.96 | Upgrade
|
| Change in Accounts Receivable | -4.8 | -4.79 | 4.91 | 4.64 | 5.09 | 3.74 | Upgrade
|
| Change in Inventory | 0.33 | -7.08 | 0.22 | 1.19 | -1.42 | - | Upgrade
|
| Change in Accounts Payable | 10.96 | 4.03 | -3.22 | -10.09 | -27.86 | -13.04 | Upgrade
|
| Change in Other Net Operating Assets | 42.97 | 76.73 | 112.9 | -35.02 | -122.85 | -162 | Upgrade
|
| Operating Cash Flow | -1,488 | -1,155 | -1,160 | -1,275 | -960.24 | -1,346 | Upgrade
|
| Capital Expenditures | 3.43 | - | -28.95 | -197.72 | -63.05 | -23.85 | Upgrade
|
| Sale of Property, Plant & Equipment | 24.21 | 24.21 | - | - | - | - | Upgrade
|
| Investment in Securities | 1,013 | 757.32 | -2,512 | -447.21 | 912.77 | 1,366 | Upgrade
|
| Other Investing Activities | 345.72 | 162.83 | 62.64 | 8.14 | -297.11 | 119.86 | Upgrade
|
| Investing Cash Flow | 1,387 | 944.36 | -2,478 | -222.29 | 558.4 | 1,462 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 39.84 | Upgrade
|
| Total Debt Issued | - | - | - | - | - | 39.84 | Upgrade
|
| Long-Term Debt Repaid | - | -8.96 | -16.03 | -15.55 | -12.49 | -6.9 | Upgrade
|
| Total Debt Repaid | -9.27 | -8.96 | -16.03 | -15.55 | -12.49 | -6.9 | Upgrade
|
| Net Debt Issued (Repaid) | -9.27 | -8.96 | -16.03 | -15.55 | -12.49 | 32.93 | Upgrade
|
| Issuance of Common Stock | - | - | 3,974 | 1,476 | - | - | Upgrade
|
| Other Financing Activities | -1.04 | -1.58 | -2.62 | -3.95 | 361.05 | -4.87 | Upgrade
|
| Financing Cash Flow | -10.31 | -10.54 | 3,955 | 1,457 | 348.56 | 28.06 | Upgrade
|
| Net Cash Flow | -111.47 | -220.87 | 317.46 | -40.75 | -53.28 | 144.48 | Upgrade
|
| Free Cash Flow | -1,484 | -1,155 | -1,189 | -1,473 | -1,023 | -1,370 | Upgrade
|
| Free Cash Flow Margin | -1764.02% | -987.51% | -874.42% | -1232.64% | -727.11% | -931.35% | Upgrade
|
| Free Cash Flow Per Share | -6.80 | -5.29 | -6.67 | -10.93 | -8.04 | -10.76 | Upgrade
|
| Cash Interest Paid | 1.58 | 1.58 | 2.62 | 3.95 | 8.15 | 4.87 | Upgrade
|
| Cash Income Tax Paid | - | -61.77 | 11.02 | 5.2 | 11.45 | 27.81 | Upgrade
|
| Levered Free Cash Flow | -799.51 | -684.75 | -826.32 | -616.13 | -702.41 | -808.73 | Upgrade
|
| Unlevered Free Cash Flow | -798.86 | -683.76 | -824.52 | -612.81 | -697.32 | -805.69 | Upgrade
|
| Change in Net Working Capital | -164.07 | -90.54 | 35.74 | -329.83 | 157.2 | 76.86 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.